HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

George Pylypchuk Selected Research

1,4-dihydropyridine (dihydropyridine)

7/2011The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
5/2010The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
5/2009The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.
6/2008The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
5/2007The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
5/2006The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.
6/2005The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


George Pylypchuk Research Topics

Disease

8Kidney Diseases (Kidney Disease)
05/2012 - 06/2005
8Hypertension (High Blood Pressure)
05/2012 - 06/2005
6Albuminuria
05/2010 - 06/2005
6Diabetes Mellitus
05/2010 - 06/2005
6Body Weight (Weight, Body)
05/2010 - 06/2005
5Heart Failure
05/2009 - 06/2005
5Myocardial Infarction
05/2009 - 06/2005
3Cardiovascular Diseases (Cardiovascular Disease)
07/2011 - 06/2005
2Dyslipidemias (Dyslipidemia)
05/2006 - 06/2005
1Atrial Fibrillation
05/2012
1Systolic Heart Failure
05/2012
1Renal Artery Obstruction (Renal Artery Stenosis)
07/2011
1Stroke (Strokes)
07/2011
1Neoplasms (Cancer)
07/2011
1Coronary Artery Disease (Coronary Atherosclerosis)
05/2010
1Chronic Kidney Failure (Chronic Renal Failure)
09/2004

Drug/Important Bio-Agent (IBA)

71,4-dihydropyridine (dihydropyridine)IBA
07/2011 - 06/2005
6Angiotensin Receptor AntagonistsIBA
07/2011 - 06/2005
6Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
07/2011 - 06/2005
6CholesterolIBA
05/2010 - 06/2005
6ThiazidesIBA
05/2010 - 06/2005
6Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2010 - 06/2005
5Calcium Channel Blockers (Blockers, Calcium Channel)IBA
05/2009 - 06/2005
4Dietary SodiumIBA
05/2010 - 05/2007
2Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
05/2010 - 05/2007
2LipidsIBA
05/2006 - 06/2005
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2006 - 06/2005
1AngiotensinsIBA
05/2012
1Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
05/2012
1A-factor (Streptomyces)IBA
05/2012
1Calcium Channels (Calcium Channel)IBA
07/2011
1MagnesiumIBA
06/2005
1CalciumIBA
06/2005
1PotassiumIBA
06/2005

Therapy/Procedure

1Renal Replacement Therapy (Therapies, Renal Replacement)
09/2004